Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Scand J Rheumatol. 2017 Sep 20;47(3):235–242. doi: 10.1080/03009742.2017.1340511

Table 2.

Association between baseline biochemical markers and baseline severity of MRI features.

Biochemical marker* P valuefor trend 0 1 2–3
Hoffa-synovitis sColl2,1NO2 (nM) 0.493
Mean (SD) - 9.31 (5.97) 9.01 (7.40) 8.32 (4.03)
OR (95% CI) - REF 0.97 (0.82, 1.15) 0.91 (0.62, 1.35)

sHA (ng/mL) 0.132
Mean (SD) - 43.93 (45.33) 50.61 (43.46) 46.79 (34.15)
OR (95% CI) - REF 1.14 (0.93, 1.39) 1.15 (0.83, 1.58)

sMMP-3 (ng/mL) 0.074
Mean (SD) - 16.90 (16.75) 17.98 (14.79) 20.34 (9.56)
OR (95% CI) - REF 1.07 (0.88, 1.30) 1.04 (0.76, 1.42)
Effusion-synovitis sColl2,1NO2 (nM) 0.641
Mean (SD) - 8.78 (5.20) 9.38 (8.40) 8.46 (3.87)
OR (95% CI) - REF 1.07 (0.87, 1.32) 1.06 (0.83, 1.34)

sHA (ng/mL) 0.007
Mean (SD) - 44.29 (43.88) 45.72 (39.08) 57.86 (45.38)
OR (95% CI) - REF 0.99 (0.79, 1.24) 1.35 (1.07, 1.71)

sMMP-3 (ng/mL) 0.032
Mean (SD) - 16.98 (17.18) 16.90 (12.71) 21.68 (16.64)
OR (95% CI) - REF 1.12 (0.87, 1.45) 1.30 (1.00, 1.69)

Adjusted for age, gender, BMI, baseline KLG.

*

Mean and standard deviation (SD) of biochemical markers are presented as non-transformed values. Odds ratio were calculated using baseline values of biochemical markers transformed to z values.